Rokit Healthcare

Rokit Healthcare FCF per Share

The Free Cash Flow per Share of Rokit Healthcare (376900.KQ) as of Nov 1, 2026 is -1,152.52 KRW. In the previous year, Free Cash Flow per Share was -648.31 KRW — a change of 77.77% (lower).

FCF per Share

-1,152.52KRW

YoY

77.77%

Last updated:

Free Cash Flow per Share of Rokit Healthcare is 2025 -1,152.52 KRW. Free Cash Flow per Share of Rokit Healthcare was 2024 -648.31 KRW. It decreases by 77.77% lower compared to the previous year.

The Rokit Healthcare FCF per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

FCF per Share
Date
FCF per Share
Jan 1, 2022
-848.45 KRW
Jan 1, 2023
-525.40 KRW
Jan 1, 2024
-648.31 KRW
Jan 1, 2025
-1,152.52 KRW
The Rokit Healthcare FCF per Share history
YEARFCF per ShareYoY
-1,152.52KRW+77.77%
-648.31KRW+23.39%
-525.40KRW-38.08%
-848.45KRW—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Rokit Healthcare Stock analysis

What does Rokit Healthcare do? Rokit Healthcare Inc develops and sells medical supplies and pharmaceutical products through its AI organ regeneration platform. The company offers three core services: medical 3-dimensional (3D) bioprinting using biocompatible materials, AI automated precision modeling for affected areas, and disposable medical device kits for assembly and disassembly. These services target healthcare providers and medical institutions seeking advanced solutions for organ regeneration and precision medical procedures. The firm also engages in manufacturing, development, sales, wholesale, and retail of medical devices, supporting both domestic and international markets. The medical 3D bioprinting service creates 3D structures with biomaterials, while the AI automated precision modeling service uses artificial intelligence to model affected areas accurately. Disposable medical device kits are sterile and designed for direct assembly and disassembly, catering to hospitals and clinics requiring efficient, sterile medical tools. Rokit Healthcare Inc's business model focuses on delivering integrated AI-driven medical solutions that combine bioprinting, modeling, and disposable device kits to enhance patient care and surgical precision. Rokit Healthcare Inc's primary revenue streams come from the sale of its AI organ regeneration platform services and the associated medical devices. Healthcare providers and medical institutions purchase these services and products to improve treatment outcomes and streamline surgical processes. The company's manufacturing and distribution activities in medical devices further contribute to its revenue, with a strong emphasis on innovation in AI and bioprinting technologies to maintain market competitiveness. Rokit Healthcare is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Rokit Healthcare stock

Free Cash Flow per Share of Rokit Healthcare is -1,152.52 KRW in 2025.

Free Cash Flow per Share of Rokit Healthcare changed from -648.31 KRW to -1,152.52 KRW, representing a 77.77% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Free Cash Flow per Share Rokit Healthcare since 2006 – with annual values, charts, and detailed analysis.

FCF per share measures the free cash flow allocated to each outstanding share. It is a key metric for assessing shareholder value creation.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Cash Flow — Rokit Healthcare

All Key Metrics — Rokit Healthcare